New funding fuels device-maker’s pursuit of FDA approval
Moximed snagged $40 million as it works to secure approval for its device, an implantable shock absorber for the knee designed to put off the […]
Moximed snagged $40 million as it works to secure approval for its device, an implantable shock absorber for the knee designed to put off the […]
There have been at least eight randomized, double-blind, placebo-controlled trials of ginger for pain. You may recall that I’ve previously explored the use of spinach […]
Unbelievably, a randomized controlled trial of cabbage leaf wraps for arthritis was published. In a section of the British Medical Journal called “Minerva,” where interesting […]
Ampio Pharma’s candidate therapy for knee osteoarthritis has been knocked back by the FDA, which will likely now require a new clinical trial of the […]
A meta-analysis of published studies looking at web- app- or telehealth-based therapy for osteoarthritis has concluded that they outperform standard approaches to care. The study […]
Date: March 7, 2022 Issue #: 1645 Summary: View the Comparison Table: Some Nonopioid Analgesics for Pain
Any lingering hope that Pfizer’s may finally get a regulatory approval for its nerve growth factor (NGF) inhibitor tanezumab looks to have been dashed after […]
Pfizer’s RSV Vaccine enters in the late-stage of clinical trials As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market […]
Shots: The P-II trial will assess the efficacy & safety of RTX across several dose groups vs PBO in patients with a mod. to sev. […]
After more than a decade of fraught clinical development it looks like the end of the line for Pfizer/Lilly painkiller tanezumab, which promised to be […]
After a long and troubled development the fate of Pfizer/Lilly’s tanezumab painkiller injection is in the balance ahead of a key meeting of advisers later […]
I recommend people switch away from using rice milk For kids and teens, the amount of arsenic flowing through their bodies was found to be […]
Shots: Merck to receive an € 50M upfront payment and € 400M development and commercial milestones and royalties on future net sales. Novartis will hold […]
Copyright © 2024 | WordPress Theme by MH Themes